Implications of T-cell P-glycoprotein activity during HIV-1 infection and its therapy.
Hulgan T, Donahue JP, Hawkins C, Unutmaz D, D'Aquila RT, Raffanti S, Nicotera F, Rebeiro P, Erdem H, Rueff M, Haas DW.
Hulgan T, et al. Among authors: haas dw.
J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):119-26. doi: 10.1097/00126334-200310010-00001.
J Acquir Immune Defic Syndr. 2003.
PMID: 14526200